FFVAX Fees and Costs — Fidelity Advisor Freedom 2015 Fund, Class A
Data updated: 2026-08-24
The net expense ratio is 0.74%: a 0.49% management fee plus a 0.25% 12b-1 fee. This share class carries a maximum front-end sales load of 5.75%. In fiscal 2026 the fund paid $5K in broker commissions, 0.0012% of average net assets, and portfolio turnover was 18%.
FFVAX Fees and Expenses
Annual operating expenses and sales charges of FFVAX. Prospectus, as of May 31, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.49% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.74% |
| Fee waiver | — |
| Net expense ratio | 0.74% |
| Sales charges | |
|---|---|
| Max front load | 5.75% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
FFVAX Costs Over Time
On $10,000 invested in FFVAX, assuming 5% a year before costs, total costs come to $1,173 over 5 years, cutting the return by 2.01% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $575 | $575 | $575 |
| Fund expenses (net expense ratio 0.74%) | $73 | $229 | $398 |
| Trading costs (broker commissions) | $0 | $0 | $1 |
| Lost growth on money paid in costs | $29 | $102 | $199 |
| Total costs | $677 | $906 | $1,173 |
| Value after costs | $9,823 | $10,670 | $11,590 |
| Impact on return, per year | 6.77% | 2.82% | 2.01% |
FFVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0012%
- Total broker commissions: $5K
- Bought from dealers (principal trades, not a cost): $4.7M
- Portfolio turnover (prospectus): 18%
- Securities lending: none during the year
FFVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| MORGAN STANLEY | $3K | 65.79% |
| JPMORGAN CHASE and CO | $644 | 12.34% |
| GOLDMAN SACHS GROUP INC (THE) | $522 | 10.00% |
| UBS GROUP AG | $188 | 3.60% |
| BARCLAYS PLC | $187 | 3.59% |
| BANK OF AMERICA CORPORATION | $172 | 3.29% |
| ROYAL BANK OF CANADA | $73 | 1.40% |
FFVAX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| WELLS FARGO and CO | $2.3M | 48.73% |
| NOMURA HOLDINGS INC | $1.3M | 27.01% |
| JEFFERIES FINANCIAL GROUP INC | $614K | 13.09% |
| CITIGROUP INC | $406K | 8.64% |
| CITADEL SECURITIES GLOBAL HOLDINGS LLC | $99K | 2.11% |
| BANK OF MONTREAL QUE | $20K | 0.42% |
Fidelity Advisor Freedom 2015 Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| FIGLX | Class K6 | 0.26% | — |
| FIJKX | Class Z | 0.44% | none |
| FFVIX | Class I | 0.49% | none |
| FFVAX | Class A | 0.74% | 5.75% |
| FFVTX | Class M | 0.99% | 3.50% |
| FFVCX | Class C | 1.49% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.